View Article

Abstract

Urolithiasis, the formation of calculi in the urinary tract, was identified as a frequent urological disorder influenced by environmental, genetic, and dietary factors. Nephrolithiasis is the formation of calculi in the kidney. Allopathic treatment was available, but it often came with side effects and a risk of recurrence, sparking curiosity in alternative methods. In addition to discussing the pathophysiology of urolithiasis, this review looked at medicinal herbs that have historically been used in treating it. Herbs with Anti-urolithiatic properties included Phyllanthus niruri, Aerva lanata, Cucumis melo, Asparagus racemosus, Scoparia dulcis, Bryophyllum pinnatum, Moringa oleifera, and Melia azedarach. They were said to have diuretic, antioxidant, and crystal-formation and aggregation-inhibiting actions. Flavonoids, alkaloids, phenolics, terpenoids, and saponins are among the bioactive substances present in these plants that have been shown to enhance kidney health and reduce the production of stones. Overall, the study indicated that herbal remedies had the potential to serve as complementary or alternative strategies in the prevention and management of urolithiasis.

Keywords

urolithiasis, nephrolithiasis, pathophysiology. Herbal remedies, phytochemicals, anti-urolithiatic activity, antioxidant activity, diuretic effect, and anti-inflammatory activity

Introduction

Urolithiasis is a multifaceted and complex urological disorder defined by the development of calculi in the kidney, bladder, and urethra. The term urolithiasis is derived from the Greek words ouron(urine), oros(flow), and lithos(stones). Urolithiasis is defined as the formation of calculi in any part of the urinary tract (like the bladder, ureter), whereas nephrolithiasis is defined as the formation of stones in the kidney. Renal calculi are most prevalent in Western countries compared to the eastern hemisphere, with an incidence rate of 1-5% in Asia, 5-9% in Europe, 12% in Canada, and 13-15% in the USA1. Renal calculi are calcium oxalate stones which is developed by the combination of calcium with oxalate in urine, leading to the formation of a crystalline structure2. It is considered the third most frequently occurring disorder of the urinary tract, after other urinary tract infections and benign prostatic hyperplasia. Nephrolithiasis is most commonly found in men compared to women in the age group between 20 and 40 in both sexes3. Risk factors include climate, dietary habits, genetics, and ethnicity4. Even though the etiology of urolithiasis remained unclear, it can be ascertained by correlation between data from laboratory and clinical sources 5. Renal calculi are formed due to the accumulation of crystals of phosphate, oxalate, uric acid, ammonium phosphate, apatite, and struvite. Approximately 75% of renal calculi are hard deposits of calcium, in which 50% is pure calcium oxalate crystal, 5% calcium phosphate crystal, 45% is a combination of both compounds. A 24-hour urine collection test helps to identify risk factors contributing to kidney stones. Some of them are:

  • Elevated levels of calcium - Hypercalciuria
  • Elevated levels of oxalates - Hyperoxaluria
  • Elevated levels of uric acid - Hyperuricaemia
  • Low levels of citrate – Hypocitraturia6.

Renal calculi can be potently treated with herbs and herbal medication, as the clinically demonstrated effects of these medications, such as immunomodulation, adaptogenicity, and antimutagenicity, have captivated public attention.

Types of Renal Calculi:

The following are types of renal calculi:

  1. Calcium oxalate stones
  2. Calcium phosphate stones
  3. Uric acid stones
  4. Struvite stones
  5. Cystine stones7

 Pathophysiology of Urolithiasis:

A biological process that involves physicochemical alteration and supersaturation of urine leads to kidney stone development. A solution that contains more dissolved material than could be dissolved by the solvent at a given temperature or pressure is referred to as a supersaturated solution, which results in precipitation of crystals in the urine 8. Further, the order of events that stimulate the stone formation inside the kidney includes nucleation, growth, aggregation, and adhesion of crystals within the kidney 9,10. The development of a nucleus from the supersaturated urine initiates the stone formation; this process is called nucleation 11,12. Crystal nucleation occurs in the kidney by free particle mechanism, where the ions or atoms present in supersaturated urine combine and form a microscopic cluster that is precipitated 13,8. These clusters present in urine adhere together to form a small solid mass stone, known as crystal growth 14. The process by which small solid masses stick together to form a large solid mass is called crystal aggregation. The attachment of developed crystals with the lining of epithelial cells in the renal tubules is referred to as crystal retention or crystal-cell interaction15,16.

Urinary supersaturation

Oxidative stress

Cell injury and cell membrane rupture

Nucleation

Crystal growth

Crystal aggregation

Crystal – cell interaction

Crystal retention or adhesion

Stone formation

Fig 01: Schematic representation of Pathophysiology of urolithiasis

Natural remedies overview:

The tiny stones do not need extensive treatments as they can be eliminated by consuming a specific amount of water. Consuming a large quantity (4-5 litres/day) of water aids in disappearance of stones from the body via urine17. Specific dietary changes can significantly assist in preventing kidney stones like reducing salt consumption and foods that are high in oxalate.

Herbal remedies:

It is estimated that 80% of the global population depends on traditional medicine for the treatment of their disease18. Medicinal herbs have history of application and are considered to be safe than the synthetic drugs19. “Pashanbheda” is ayurvedic term used to refer the plant which is having the ability to dissolve or disintegrate the stones. Some natural herbs used in urolithiasis treatment,

  1. Phyllanthus niruri (L).

Phyllanthus niruri L. is generally known as ‘Bhumi amla’ or ‘Stone breaker’, belonging to the Euphorbiaceae family. It has been utilized as a remedy in Ayurveda for centuries. In Charaka Samhita, it is stated to be advantageous in treating different health issues. The extract of this plant is said to be beneficial in hepatitis and AIDS, and it also possesses anti-viral, anti-fungal, anti-inflammatory, anti-oxidant, hepatoprotective, hypoglycaemic, hypotensive, and analgesic properties. The active ingredient in Phyllanthus niruri L. is niruriside, it also contains numerous bioactive compounds like lignans, phyllanthin, flavonoids, hypophyllanthin, tannins, alkaloids, glycosides, triterpenes, phenylpropanoids, steroids, phyltetralin, and ricinolic acid 20. Biochemical compounds discovered in this plant are shown to exhibit an inhibiting effect on stones. The triterpenes have been observed to suppress the cytotoxicity caused by calcium oxalate and also lower the excretion of constituents that form kidney stones, along with the indicators of crystal deposition in the kidneys21. The root of this plant is also said to facilitate the removal of stones in individuals with kidney stones, along with the normalisation of calcium levels in patients with hypercalciuria20. The aqueous extract of Phyllanthus niruri L. was observed to have a strong inhibitory effect on the development of matrix calculus and decreases the quantity of stone; it might affect the initial phases (crystal growth and aggregation) of stone formation and could signify a different method of treatment or prevention for urolithiasis22.

Fig 02: Phyllanthus niruri (L.)

  1. Aerva lanata (L):

As a member of Amaranthaceae family, Aerva lanata (L) is also called as Pashanabheda, Bhui and Gorakshaganjaa, which has several therapeutic applications, such as diuretic and anti-urolithiatic activity, anti-microbial activity, anti-fertility activity, anti-parasitic, anti-asthmatic, and anti-diabetic activity. In the Indian traditional medical system, ayurvedic practitioner uses the whole Aerva lanata plant as an anti-urolithiatic medication. It has several phytochemical components that have been identified to be responsible for variety of therapeutic activities. It includes alkaloids (like ervolanine, aervolanine, ervoside, ervine, methylervine), flavonoids (like quercetin, kaempferol, isorhamnetin, flavanone glucoside persinol, persinosides A and B), terpenoids (lupeol, betulin, beta-Sitosterol), phenolic compounds, tannins, and saponins. Roots of this plant are used to treat headaches as well as a demulcent. Quercetin and betulin were isolated from the plant and mainly show anti-urolithiatic activity by inhibiting oxalate oxidase enzyme activity (causes stone formation), leading to decreased production of oxalates23,24.

Fig 03: Aerva lanata (L.)

  1. Cucumis melo (L.):

The eudicot diploid plant species known as muskmelon (Cucumis melo L.) is a member of Cucurbitaceae family, which is a species of Cucumis and is produced all over the world for its nutritional and commercial benefits. There are many varieties of active ingredients present in different parts of melon, the peel and seeds of melon contains phenolic acids like hydroxybenzoic acid (gallic acid, isovanillic acid, 3 and 4 hydroxybenzoic acid), methoxybenzoic acid (vanillic acid) and hydroxycinnamic acid (coumaric acid, chlorogenic acid), flavones and flavanones (luteolin-7-glycoside, naringenin), phenolic alcohols(tyrosol), phenylethanoids, benzenacetic acid derivatives, aromatic aldehydes(vanillin), vitamin E and secoiridoides. The pulp of melon contains tetraterpenoids (beta carotene), vitamin C (ascorbic acid). The medicinal activity exhibited by melons is anti-oxidant activity, analgesic activity, anti-inflammatory activity, anti-ulcer activity, anti-hypothyroidism, anti-diabetic, and anti-bacterial activity. Elevated levels of uric acid, creatine and blood urea nitrogen (BUN) are the important markers of renal injury brought by stones, the anti-urolithiatic activity of methanol and chloroform extract of melons peel and pulp shows significant reduction in renal calculi by decreasing the levels of indicators of the kidney (flavonoids and phenolic compound from extract prevent crystal formation, oxidative stress and inflammation)25,26.

Fig 04: Cucumis melo (L.)

  1. Asparagus racemosus:

Shatavari, Satavari, and Asvel are the synonyms of the therapeutic plant Asparagus racemosus belonging to the family Asparagaceae, which has abundant phytochemical, nutritional and medical properties (especially roots). It consist of alkaloids (Asparagamine A, polycyclic alkaloids), flavonoids (quercetin, rutin, kaempferol, cynidin-3-glucoronide), steroidal saponins (Shatavarins, asparanin, adscendin), immunoside or oligospirostanoside (Racemoside, shatavaroside), sterols (Diosgenin, sitosterol), phenanthrene and furan derivatives, carbohydrates and polysaccharides, trace elements like zinc, iron, magnesium, potassium, calcium present mainly in roots as well as essential oil, tannins and quinones (anthraquinone). It exhibits multiple pharmacological actions like anti-depressant, anti-tussive, neuroprotective, anti-bacterial, anti-oxidant, anti-diabetic, anti-ulcer, nootropic, immunomodulatory, anti-inflammatory, anti-cancer, anti-urolithiatic and hepatoprotective action. The aqueous root extract of Asparagus racemosus shows anti-urolithiatic activity by inhibiting steps involved in kidney stone formation (step shown in Fig. 01). It also changes the calcium oxalate crystal structure from monohydrate to dihydrate, which is unstable and less likely to adhere to the walls of the kidney or renal tubular cells and is easily eliminated in urine. The phytochemicals from the extract form a soluble complex by binding with calcium ions and other compounds that form stones, causing less free and insoluble calcium availability for stone formation27,28.

Fig 05: Asparagus racemosus

  1. Scoparia dulcis:

The plant Scoparia dulcis belongs to the Scrophulariaceae family, commonly called sweet broom weed, Mithipatti, Ghodatulsi. It exhibits various pharmacological and medicinal properties with numerous phytochemical constituents. Some constituents are flavonoids (luteolin, apigenin, cirsimarin, vitexin), steroids and triterpenes (betulinic acids, glutinol, stigmasterol), terpenoids and diterpenes (scopadulcic acid A and B, scopadulin, scoparic acid), phenols, polyphenols, amino acids, catechol amines, tannins, and coumarins. The pharmacological activities of this plant are anti-microbial, anti-fungal, anti-diabetic, nephroprotective, analgesic, anti-inflammatory, anti-pyretic, anti-ulcer, anti-urolithiatic, anti-sickling, anti-allergenic, and anti-hyperlipidemic as well as sedative and hypnotics. Serum levels of creatine, uric acid, and marker enzymes like ACP, ALP, AST, and ALT rise as a result of kidney stone development, leading to renal injury. These parameters nearly returned to normal after receiving the ethanolic leaf extract of Scoparia dulcis treatment. It indicates that kidney function had been restored and that stone development is decreased. The extract opposes the ethylene glycol-induced oxidative damage and hyperoxaluria, it may reduce renal tissue damage and stop the formation of calcium oxalate crystals, maintain kidney function, and normalize biochemical indicators to act as an anti-urolithiatic agent29,30,31.

Fig 06: Scoparia dulcis

  1. Bryophyllum pinnatum (Lam.):

Bryophyllum pinnatum (Lam.), belonging to the Crassulaceae family, kalanchoe pinnata, pers and Bryophyllum calycinum salisb are synonyms. The common names of this plant are parnabija, Canterbury, love plant, air plant, cathedral bells, and zakham-e-hyat. In traditional medicine, Bryophyllum pinnata is widely used to treat a variety of illnesses. It has significant pharmacological activity due to various phytochemicals or active medicinal ingredients present in the plant abundantly. The phytochemicals are alkaloids, flavonoids(kaempferol, rutin, quercetin, luteolin and glycosylated flavones), phenolic acids and phenylpropanoids(syringic acid, caffeic acid, ferulic acid, p-coumaric acid, phosphoenolpyruvate and hydroxycinnamic acid), triterpenoids(alpha and beta amyrin, pseudo taraxasterol, taraxerol, friedelin, glutinol, bryophollenone and bryophollone), steroids and cardiac glycosides(bufadienolides, beta sitosterol, stigmasterol, campesterol, bryophyllin A,B,C, bryotoxins, clerosterol, ergosta type sterols, digoxin and digitoxin), amino acids and proteins(glycine, cysteine, tyrosine, phenylalanine, glutamic acid, methionine), carbohydrates and sugars(lactose, sucrose, glucose, raffinose, fructose, galactose), minerals(sodium, calcium, potassium, magnesium, iron, copper, zinc, iodine), tannins, phenanthrene derivatives, vitamins(vit.C, vit.B1,2,3,6), lipids and fatty acids(palmitic acid, stearic acid, arachidic acid, behenic acid), organic acids(isocitric acid, succinic acid, citric acid, oxalic acid, malic acid, oxaloacetate) and small traces of toxic compound hydrogen cyanide. The therapeutic activity possessed by this plant is anti-oxidant, anti-inflammatory, diuretic, anti-lithic, anti-tumor, cytotoxic-anticancer, anti-ulcer, anti-oxidant, anti-microbial, immunomodulatory, anti-viral, nephroprotective, astringent, cardio protective, anti-coagulant, and hypocholesterolemic activities. The hydroalcoholic extract of this plant shows anti-urolithiatic activity by reducing the levels of stone-forming ions, enhancing urine production to remove stones, defending renal tissue from oxidative stress or damage, and encourages stone dissolution or disintegration, also prevents stone reccurance32,33.

Fig 07: Bryophyllum pinnatum (Lam.)

  1. Moringa oleifera:

Moringa oleifera, also known as drumstick, subhanjana, morigkai, saguna, belonging to the family Moringaceae, grows widely in India and tropical regions. The leaves, bark, roots, and flower parts of this plant have various beneficial therapeutic uses. The leaves of this plant are enriched in potassium, calcium, beta carotene, and other vital elements, which is used to treat malnutrition in infants and nursing women. The roots are traditionally utilized to treat paralysis and helminthiasis. Bark is used to treat toothaches, ulcers, and hypertension. Moringa oleifera contains major phytochemicals like flavonoids(rutin, kaempferol, quercetin, myricetin, isorhamnetin, procyanidins), glucosinolates and their derivatives like glucomoringin, niazirin, niazirinin, niazimin A and B, phenolic compounds(coumaric acid, ferulic acid, caffeic acid, gallic acid, ellagic acid, sinapic acid, syringic acid), fatty acids like oleic acid, palmitic acid, arachidic acid, phytosterols like beta-sitosterol, stigmasterol, vitamins like beta-carotene, alpha-tocopherol, and carbohydrates like mannose. The pharmacological activity shown by this plant is anti-inflammatory, anti-microbial, anti-cancer, anti-oxidant, anti-urolithiatic, diuretic, anti-fertility, hepatoprotective, anti-ulcer, anti-pyretic, anti-diabetic, cardiovascular, analgesic, anti-allergic, wound healing, anti-helminthic, local anaesthetic, and CNS activity. The aqueous extract of the bark of this plant shows a significant decrease in the stone weight, inhibits nucleation, and urinary crystal growth. The diuresis activity causes a decrease in supersaturation of urine, increases urine volume, and dilutes salts, which causes stones34,35,36.

Fig 08: Moringa oleifera

  1. Melia azedarach Linn:

Melia azedarach Linn is a tiny shrub closely related to the neem plant, belonging to Meliaceae family. It is commonly called as chinaberry, Indian lilac, padric, cinnamumo, bakain, This plant possess various phytochemicals like terpenoids, diterpenes like phytol, squalene, azedarachtin A and b, flavonoids like quercetin, rutin, kaempferol, isoquercetin, tetra-nor-triterpenoids or limonoids like meliacarpin, meliartenin, melianol, meliacin, steroids like stigmasterol, beta-sitosterol, campesterol, phenolic compounds like vanillin, vanillic acid, benzoic acid, hydroxyl-3-methoxycinnamaldehyde, alkaloids or beta-carboline alkaloids like 4,8-dimethoxy-1-vinyl-beta-carboline, fatty acids like palmitic acid, pentadecanoic acid, hexadecenoic acid, anthraquinones compounds like 1,3,5,8-tetrahydroxy-2-methylanthraquinones and vitamins A and E. The medicinal properties of this plant are anti-oxidant, anti-fertility, hepatoprotective, anti-pyretic, anti-bacterial, anti-viral, anti-nephrolithiasis, anti-ulcer, anti-malarial, anti-protozoal, anti-helminthic, cytotoxic activity, wound healing capacity, and diuretic activity. The aqueous leaf extract of the plants shows anti-urolithiasis by reducing elevated levels of oxalates, inhibiting crystal nucleation and aggregation, maintaining serum creatine level, uric acid, and blood urea nitrogen (BUN) levels, flushing out small stones by enhanced urine output37,38.

Fig 09: Melia azedarach Linn

Table 01: List of plants with active components and their role as anti-urolithiatic activity

Plant

Scientific name

Family

Part of the plant and extract used

Anti-urolithiasis effect

Bhumi amla

Phyllanthus niruri (L.)

Euphorbiaceae

 

Aqueous extract of the whole plant

Inhibition of the development of matrix calculus or inhibits the initial stages of stone formation.

Gorakshaganjaa or Bhui

Aerva lanata (L.)

Amaranthaceae

Hydroalcoholic extract of dried plant

Inhibition of oxalate oxidase enzyme activity leads to a decrease in the production of oxalate crystals.

Muskmelon

Cucumis melo (L.)

Cucurbitaceae

Methanolic extract of peel and chloroform extract of pulp

Reduction in elevated levels of serum creatine, BUN, and uric acid, as well as preventing crystal formation and oxidative stress caused by stones.

Shatavari or satavari

Asparagus racemosus

Asparagaceae

Aqueous root extract

It converts calcium oxalate crystal structure from monohydrate to dihydrate, which is unstable and less likely to adhere to the walls of the kidney. It also forms a soluble complex with calcium ions and makes less available free ca+2 for stone development.

Ghodatulsi, or sweet broom weed, or mithipatti

Scoparia dulcis

Scrophulariaceae

Ethanolic leaf extract

The biomarkers of kidney stones are reduced, decreasing stone formation, reducing oxidative stress, and hyperoxaluria levels.

Kalanchoe pinnata or parnabija

Bryophyllum pinnatum (Lam.)

Crassulaceae

Hydroalcoholic leaf extract

It reduces levels of stone-forming ions and enhances urine production to flush out stones.

Drumstick or morigkai

Moringa oleifera

Moringaceae

Aqueous extract of the plant's bark

Inhibition of nucleation and urinary crystal growth by decreasing the supersaturation of urine.

Indian lilac or chinaberry

Melia azedarach Linn

Meliaceae

Aqueous leaf extract

It reduces hyperoxaluria and inhibits crystal nucleation and aggregation. Enhanced urine output causes flushing of stones.

CONCLUSION:

Urolithiasis remains a major health concern due to its recurrent nature and high frequency. The use of herbal remedies, which were common in older medical systems, may be advantageous as safer and more helpful alternatives for kidney stone treatment. The plants examined in this study demonstrated a variety of methods of action that preserved renal tissue, slowed the formation of stones, and made it easier to remove them. To ensure the safety and therapeutic effectiveness of herbal preparations, however, clinical validation and standardization were still necessary. A viable method for enhancing long-term results in urolithiasis patients seemed to be in combination with researched herbal remedies and traditional therapies.

REFERENCES

  1. Allam, E. A. H. (2024). Urolithiasis unveiled: pathophysiology, stone dynamics, types, and inhibitory mechanisms: a review. In African Journal of Urology (Vol. 30, Issue 1). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1186/s12301-024-00436-z
  2. Sellaturay S, Fry C (2008) The metabolic basis for urolithiasis. Surgery 26:136–40. https://doi.org/10.1016/j.mpsur.2008.03.002  
  3. Kantivan Goswami, P., Srivastava, R. S., Samant, M., & Khale, A. (2013). Urolithiasis: An Overview. In International Journal of Pharmaceutical & Biological Archives (Vol. 4, Issue 6). www.ijpba.info
  4. Ba?tu? F, Dü?ünsel R (2012) Pediatric urolithiasis: causative factors, diagnosis and medical management. Nat Rev Urol 9:138–146. https:// doi.org/10.1038/nrurol.2012.4
  5. Keyser Ld. Recurrent Urolithiasis: Etiologic Factors and Clinical Management. Jama. 1935;104(15):1299–1306. doi:10.1001/jama.1935.02760150011003
  6. Khan, F., Haider, M. F., Singh, M. K., Sharma, P., Kumar, T., & Neda, E. N. (2019). A comprehensive review on kidney stones, its diagnosis and treatment with allopathic and ayurvedic medicines. Urology & Nephrology Open Access Journal, 7(4). https://doi.org/10.15406/unoaj.2019.07.00247
  7. Bushinsky DA, Walter RP, John RA. Calcium phosphate supersaturation regulates stoneformation in genetic hypercalciuricstone-forming rats. Kidney Int2000; 57:550-560.
  8. D. R. Basavaraj, C. S. Biyani, A. J. Browning, and J. J. Cartledge, “, the role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones,” EAU-EBU Update Series, vol. 5, no. 3, pp. 126–136, 2007.
  9. N. Chhiber, M. Sharma, T. Kaur, and S. Singla, “Mineralization in health and mechanism of kidney stone formation,” International Journal of Pharmaceutical Science Invention, vol. 3, pp. 25–31, 2014.
  10. P. Cunningham, H. Noble, A.-K. Al-Modhefer, and I. Walsh, “Kidney stones: pathophysiology, diagnosis and management,” British Journal of Nursing, vol. 25, no. 20, pp. 1112–1116, 2016.
  11. S. B. N. Kumar, K. G. Kumar, V. Srinivasa, and S. Bilal, “A review on urolithiasis,” International Journal of Universal Pharmacy and Life Sciences, vol. 2, no. 2, pp. 269–280, 2012.
  12. S. R. Khan and D. J. Kok, “Modulators of urinary stone formation,” Frontiers in Bioscience, vol. 9, no. 1–3, pp. 1450–1482, 2004.
  13. A. P. Evan, “Physiopathology and Etiology of stone formation in the kidney and the urinary tract,” Pediatric Nephrology, vol. 25, no. 5, pp. 831–841, 2010.
  14. V. N. Ratkalkar and J. G. Kleinman, “Mechanisms of stone formation,” Clinical Reviews in Bone and Mineral Metabolism, vol. 9, no. 3-4, pp. 187–197, 2011.
  15. K. P. Aggarwal, S. Narula, M. Kakkar, and C. Tandon, “Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators,” BioMed Research International, vol. 2013, Article ID 292953, 21 pages, 2013.
  16. M. S. Schepers, B. G. Vander, J. C. Romijn, F. H. Schrooderand, and C. F. Verkoelen, “Urinary crystallization inhibitors do not prevent crystal binding,” Journal of Urology, vol. 167, no. 4, pp. 1844–1847, 2002.
  17. Ohkawa M, Tokunaga S, Nakashima T, et al. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol. 1992;69(6):571–576.
  18. Kennedy J. Herb and supplement use in the US adult population. Clin Ther. 2005; 27:1847-58. doi: 10.1016/j. clinthera.2005.11.004.
  19.  Nasri H, Shirzad H. Toxicity and safety of medicinal plants. J HerbMed Plarmacol. 2013; 2:21-2.
  20. Narendra K, Swathi J, Sowjanya K, Satya A. Phyllanthus niruri: A Review on its Ethno Botanical, Phytochemical and Pharmacological Profile. 2012; 5(9): 4681 4691.
  21. Mirian A. Boim, Ita P. Heilberg, Nestor Schor. Phyllanthus niruri as a Promising Alternative Treatment for Nephrolithiasis.
  22. Barros M, Schor A, Boim M. Effects of an aqueous extract from Phyllanthus niruri on calcium oxalate crystallization 2003;30(6):374–379.
  23. Goyal, M., Pareek, A., Nagori, B. P., & Sasmal, D. (2011). Aerva lanata: A review on phytochemistry and pharmacological aspects. In Pharmacognosy Reviews (Vol. 5, Issue 10, pp. 195–198). https://doi.org/10.4103/0973-7847.91120
  24. Dinnimath BM, Jalalpure SS, Patil UK. Antiurolithiatic activity of natural constituents isolated from Aerva lanata. J Ayurveda Integr Med. 2017 Oct-Dec;8(4):226-232. doi: 10.1016/j.jaim.2016.11.006. Epub 2017 Nov 21. PMID: 29169771; PMCID: PMC5747499.
  25. Narkhede, M. B., Gaikwad, K. P., Ambhore, J. P., & Chandak, C. S. (2024). An Overview Of Cucumis Melo L.’S Physicochemical Traits And Health-Promoting Qualities. International Journal of Pharmacognosy, 11(9), 445–451. https://doi.org/10.13040/IJPSR.0975-8232.IJP.11(9).445-51
  26. Saleem, A., Islam, M., Saeed, H., & Iqtedar, M. (2021). In-vivo evaluation of anti-urolithiatic activity of different extracts of peel and pulp of cucumis melo l. In mice model of kidney stone formation. Pakistan Journal of Zoology, 53(4), 1435–1440. https://doi.org/10.17582/journal.pjz/20190418170457
  27. Javaid, K., Hussain, S., Syed, S. K., Ahmad, I., Massey, S., Asghar, A., Ahmad, I., Amjad, M., Rukhsar, A., & Hafeez, M. (2022). Phytochemistry, Medicinal And Nutritional Importance Of Asparagus Racemosus. Post?py Biologii Komórki, 49(3), 175–192. https://doi.org/10.59674/pbk2
  28. Kishore, B., Prasanna Raju, Y., & Chandra Sekhar Kothapalli, B. (2020). Evaluation of Antiurolithiatic Activity of Asparagus Racemosus on In Vitro Calcium Oxalate Crystallization Methods. International Journal of Pharma and Bio Sciences, 10(5). https://doi.org/10.22376/ijpbs/lpr.2020.10.5.p56-62
  29. Sarkar, A., Ghosh, P., Poddar, S., Sarkar, T., Choudhury, S., & Chatterjee, S. (2020). Phytochemical, botanical and Ethnopharmacological study of Scoparia dulcis Linn. (Scrophulariaceae): A concise review. The Pharma Innovation, 9(7), 30–35. https://doi.org/10.22271/tpi.2020.v9.i7a.5049
  30. Paul, M., Vasudevan, K., & R, K. K. (n.d.). Scoparia Dulcis: A Review on Its Phytochemical And Pharmacological Profile. In Innoriginal International Journal of Sciences | (Vol. 4).
  31. Antiurolithiatic Activity of Scoparia Dulcis In Ethylene Glycol Induced Urolithiasis In Male Albino Wistar Rats. (n.d.). www.wjpr.net
  32. Kamboj, A., & Saluja, A. K. (2009). Bryophyllum pinnatum (Lam.) Kurz.: Phytochemical and Pharmacological Profile: A Review. In Phcog Rev (Vol. 3). www.phcog.net
  33. Pandhare, R. B., Shende, R. R., Avhad, M. S., Deshmukh, V. K., Mohite, P. B., Sangameswaran, B., & Daude, R. B. (2021). Anti-urolithiatic activity of Bryophyllum pinnatum Lam. hydroalcoholic extract in sodium oxalate-induced urolithiasis in rats. Journal of Traditional and Complementary Medicine, 11(6), 545–551. https://doi.org/10.1016/j.jtcme.2021.06.002
  34. Mishra, G., Singh, P., & Kumar, S. (n.d.). Traditional uses, phytochemistry and pharmacological properties of Moringa oleifera plant: An overview. www.scholarsresearchlibrary.com
  35. Pareek, A., Pant, M., Gupta, M. M., Kashania, P., Ratan, Y., Jain, V., Pareek, A., & Chuturgoon, A. A. (2023). Moringa oleifera: An Updated Comprehensive Review of Its Pharmacological Activities, Ethnomedicinal, Phytopharmaceutical Formulation, Clinical, Phytochemical, and Toxicological Aspects. In International Journal of Molecular Sciences (Vol. 24, Issue 3). MDPI. https://doi.org/10.3390/ijms24032098
  36. Fahad, J., . V., Kumar, M. C. S., . S., Kodancha, G. P., Adarsh, B., Udupa, A. L., & Rathnakar, U. P. (2010). Antiurolithiatic activity of aqueous extract of bark of moringa oleifera (lam.) in rats. Health, 02(04), 352–355. https://doi.org/10.4236/health.2010.24053
  37. Pharmaceut, A. J., Sultana, S., Asif, H. M., Akhtar, N., Waqas, M., & Rehman, S. U. (n.d.). Review On Melia Azedarach Linn Ajprhc Comprehensive Review On Ethanobotanical Uses, Phytochemistry And Pharmacological Properties Of Melia Azedarach Linn. In Res Health Care (Vol. 6). www.jprhc.in
  38. Dharmalingam, S. R., Madhappan, R., Chidambaram, K., Ramamurthy, S., Gopal, K., Swetha, P., & Kumar, K. L. S. (2014). Anti-urolithiatic activity of Melia azedarach Linn leaf extract in ethylene glycol-induced urolithiasis in male albino rats. Tropical Journal of Pharmaceutical Research, 13(3), 391–397. https://doi.org/10.4314/tjpr.v13i3.12.

Reference

  1. Allam, E. A. H. (2024). Urolithiasis unveiled: pathophysiology, stone dynamics, types, and inhibitory mechanisms: a review. In African Journal of Urology (Vol. 30, Issue 1). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1186/s12301-024-00436-z
  2. Sellaturay S, Fry C (2008) The metabolic basis for urolithiasis. Surgery 26:136–40. https://doi.org/10.1016/j.mpsur.2008.03.002  
  3. Kantivan Goswami, P., Srivastava, R. S., Samant, M., & Khale, A. (2013). Urolithiasis: An Overview. In International Journal of Pharmaceutical & Biological Archives (Vol. 4, Issue 6). www.ijpba.info
  4. Ba?tu? F, Dü?ünsel R (2012) Pediatric urolithiasis: causative factors, diagnosis and medical management. Nat Rev Urol 9:138–146. https:// doi.org/10.1038/nrurol.2012.4
  5. Keyser Ld. Recurrent Urolithiasis: Etiologic Factors and Clinical Management. Jama. 1935;104(15):1299–1306. doi:10.1001/jama.1935.02760150011003
  6. Khan, F., Haider, M. F., Singh, M. K., Sharma, P., Kumar, T., & Neda, E. N. (2019). A comprehensive review on kidney stones, its diagnosis and treatment with allopathic and ayurvedic medicines. Urology & Nephrology Open Access Journal, 7(4). https://doi.org/10.15406/unoaj.2019.07.00247
  7. Bushinsky DA, Walter RP, John RA. Calcium phosphate supersaturation regulates stoneformation in genetic hypercalciuricstone-forming rats. Kidney Int2000; 57:550-560.
  8. D. R. Basavaraj, C. S. Biyani, A. J. Browning, and J. J. Cartledge, “, the role of urinary kidney stone inhibitors and promoters in the pathogenesis of calcium containing renal stones,” EAU-EBU Update Series, vol. 5, no. 3, pp. 126–136, 2007.
  9. N. Chhiber, M. Sharma, T. Kaur, and S. Singla, “Mineralization in health and mechanism of kidney stone formation,” International Journal of Pharmaceutical Science Invention, vol. 3, pp. 25–31, 2014.
  10. P. Cunningham, H. Noble, A.-K. Al-Modhefer, and I. Walsh, “Kidney stones: pathophysiology, diagnosis and management,” British Journal of Nursing, vol. 25, no. 20, pp. 1112–1116, 2016.
  11. S. B. N. Kumar, K. G. Kumar, V. Srinivasa, and S. Bilal, “A review on urolithiasis,” International Journal of Universal Pharmacy and Life Sciences, vol. 2, no. 2, pp. 269–280, 2012.
  12. S. R. Khan and D. J. Kok, “Modulators of urinary stone formation,” Frontiers in Bioscience, vol. 9, no. 1–3, pp. 1450–1482, 2004.
  13. A. P. Evan, “Physiopathology and Etiology of stone formation in the kidney and the urinary tract,” Pediatric Nephrology, vol. 25, no. 5, pp. 831–841, 2010.
  14. V. N. Ratkalkar and J. G. Kleinman, “Mechanisms of stone formation,” Clinical Reviews in Bone and Mineral Metabolism, vol. 9, no. 3-4, pp. 187–197, 2011.
  15. K. P. Aggarwal, S. Narula, M. Kakkar, and C. Tandon, “Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators,” BioMed Research International, vol. 2013, Article ID 292953, 21 pages, 2013.
  16. M. S. Schepers, B. G. Vander, J. C. Romijn, F. H. Schrooderand, and C. F. Verkoelen, “Urinary crystallization inhibitors do not prevent crystal binding,” Journal of Urology, vol. 167, no. 4, pp. 1844–1847, 2002.
  17. Ohkawa M, Tokunaga S, Nakashima T, et al. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol. 1992;69(6):571–576.
  18. Kennedy J. Herb and supplement use in the US adult population. Clin Ther. 2005; 27:1847-58. doi: 10.1016/j. clinthera.2005.11.004.
  19.  Nasri H, Shirzad H. Toxicity and safety of medicinal plants. J HerbMed Plarmacol. 2013; 2:21-2.
  20. Narendra K, Swathi J, Sowjanya K, Satya A. Phyllanthus niruri: A Review on its Ethno Botanical, Phytochemical and Pharmacological Profile. 2012; 5(9): 4681 4691.
  21. Mirian A. Boim, Ita P. Heilberg, Nestor Schor. Phyllanthus niruri as a Promising Alternative Treatment for Nephrolithiasis.
  22. Barros M, Schor A, Boim M. Effects of an aqueous extract from Phyllanthus niruri on calcium oxalate crystallization 2003;30(6):374–379.
  23. Goyal, M., Pareek, A., Nagori, B. P., & Sasmal, D. (2011). Aerva lanata: A review on phytochemistry and pharmacological aspects. In Pharmacognosy Reviews (Vol. 5, Issue 10, pp. 195–198). https://doi.org/10.4103/0973-7847.91120
  24. Dinnimath BM, Jalalpure SS, Patil UK. Antiurolithiatic activity of natural constituents isolated from Aerva lanata. J Ayurveda Integr Med. 2017 Oct-Dec;8(4):226-232. doi: 10.1016/j.jaim.2016.11.006. Epub 2017 Nov 21. PMID: 29169771; PMCID: PMC5747499.
  25. Narkhede, M. B., Gaikwad, K. P., Ambhore, J. P., & Chandak, C. S. (2024). An Overview Of Cucumis Melo L.’S Physicochemical Traits And Health-Promoting Qualities. International Journal of Pharmacognosy, 11(9), 445–451. https://doi.org/10.13040/IJPSR.0975-8232.IJP.11(9).445-51
  26. Saleem, A., Islam, M., Saeed, H., & Iqtedar, M. (2021). In-vivo evaluation of anti-urolithiatic activity of different extracts of peel and pulp of cucumis melo l. In mice model of kidney stone formation. Pakistan Journal of Zoology, 53(4), 1435–1440. https://doi.org/10.17582/journal.pjz/20190418170457
  27. Javaid, K., Hussain, S., Syed, S. K., Ahmad, I., Massey, S., Asghar, A., Ahmad, I., Amjad, M., Rukhsar, A., & Hafeez, M. (2022). Phytochemistry, Medicinal And Nutritional Importance Of Asparagus Racemosus. Post?py Biologii Komórki, 49(3), 175–192. https://doi.org/10.59674/pbk2
  28. Kishore, B., Prasanna Raju, Y., & Chandra Sekhar Kothapalli, B. (2020). Evaluation of Antiurolithiatic Activity of Asparagus Racemosus on In Vitro Calcium Oxalate Crystallization Methods. International Journal of Pharma and Bio Sciences, 10(5). https://doi.org/10.22376/ijpbs/lpr.2020.10.5.p56-62
  29. Sarkar, A., Ghosh, P., Poddar, S., Sarkar, T., Choudhury, S., & Chatterjee, S. (2020). Phytochemical, botanical and Ethnopharmacological study of Scoparia dulcis Linn. (Scrophulariaceae): A concise review. The Pharma Innovation, 9(7), 30–35. https://doi.org/10.22271/tpi.2020.v9.i7a.5049
  30. Paul, M., Vasudevan, K., & R, K. K. (n.d.). Scoparia Dulcis: A Review on Its Phytochemical And Pharmacological Profile. In Innoriginal International Journal of Sciences | (Vol. 4).
  31. Antiurolithiatic Activity of Scoparia Dulcis In Ethylene Glycol Induced Urolithiasis In Male Albino Wistar Rats. (n.d.). www.wjpr.net
  32. Kamboj, A., & Saluja, A. K. (2009). Bryophyllum pinnatum (Lam.) Kurz.: Phytochemical and Pharmacological Profile: A Review. In Phcog Rev (Vol. 3). www.phcog.net
  33. Pandhare, R. B., Shende, R. R., Avhad, M. S., Deshmukh, V. K., Mohite, P. B., Sangameswaran, B., & Daude, R. B. (2021). Anti-urolithiatic activity of Bryophyllum pinnatum Lam. hydroalcoholic extract in sodium oxalate-induced urolithiasis in rats. Journal of Traditional and Complementary Medicine, 11(6), 545–551. https://doi.org/10.1016/j.jtcme.2021.06.002
  34. Mishra, G., Singh, P., & Kumar, S. (n.d.). Traditional uses, phytochemistry and pharmacological properties of Moringa oleifera plant: An overview. www.scholarsresearchlibrary.com
  35. Pareek, A., Pant, M., Gupta, M. M., Kashania, P., Ratan, Y., Jain, V., Pareek, A., & Chuturgoon, A. A. (2023). Moringa oleifera: An Updated Comprehensive Review of Its Pharmacological Activities, Ethnomedicinal, Phytopharmaceutical Formulation, Clinical, Phytochemical, and Toxicological Aspects. In International Journal of Molecular Sciences (Vol. 24, Issue 3). MDPI. https://doi.org/10.3390/ijms24032098
  36. Fahad, J., . V., Kumar, M. C. S., . S., Kodancha, G. P., Adarsh, B., Udupa, A. L., & Rathnakar, U. P. (2010). Antiurolithiatic activity of aqueous extract of bark of moringa oleifera (lam.) in rats. Health, 02(04), 352–355. https://doi.org/10.4236/health.2010.24053
  37. Pharmaceut, A. J., Sultana, S., Asif, H. M., Akhtar, N., Waqas, M., & Rehman, S. U. (n.d.). Review On Melia Azedarach Linn Ajprhc Comprehensive Review On Ethanobotanical Uses, Phytochemistry And Pharmacological Properties Of Melia Azedarach Linn. In Res Health Care (Vol. 6). www.jprhc.in
  38. Dharmalingam, S. R., Madhappan, R., Chidambaram, K., Ramamurthy, S., Gopal, K., Swetha, P., & Kumar, K. L. S. (2014). Anti-urolithiatic activity of Melia azedarach Linn leaf extract in ethylene glycol-induced urolithiasis in male albino rats. Tropical Journal of Pharmaceutical Research, 13(3), 391–397. https://doi.org/10.4314/tjpr.v13i3.12.

Photo
A. Sravanthi
Corresponding author

Department of Pharmacology, The Oxford College of Pharmacy

Photo
Meghna
Co-author

Department of Pharmacology, The Oxford College of Pharmacy

Photo
Mohamed Ashwaq S.
Co-author

Department of Pharmacology, The Oxford College of Pharmacy

Photo
Mohammed Sameer H.
Co-author

Department of Pharmacology, The Oxford College of Pharmacy

Photo
Mouneshwar V.
Co-author

Department of Pharmacology, The Oxford College of Pharmacy

A. Sravanthi, Meghna, Mohamed Ashwaq S., Mohammed Sameer H., Mouneshwar V., Nature's Remedy: The Role of Herbs in Urolithiasis Treatment, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 11, 2757-2768. https://doi.org/10.5281/zenodo.17645822

More related articles
Exploring Digital Health Literacy among the Elderl...
Binu K M, H. Doddayya, Akshay J, Nuzhat Fatima, Pranotosh Mondal,...
Neuroprotective Agents in the Management of Alzhei...
Kajal Dhum, Dr. Sonali Uppalwar, ...
Rediscovering the Therapeutic Potential of Rhus Species - A Review...
U. Brundha, P. Jaganatha, K. Aparna, Arnab Maiti, T. Bhumika, ...
Antiepileptic Drug Interactions in Polytherapy Patients...
Aneeta G Jacob, J. S. Venkatesh, Dr. Santosh Uttangi, Aleena R Reji, Bhoomika K S, Dona Aju, ...
Related Articles
Uterine Fibroids: From Pathogenic Signalling and Molecular Classification to Pre...
Dr. Subashini R, Abinaya S, Anupama Sankar, Christy Immaculate J, Abitha P, ...
A Review Article on Tablet Defects and Their Remedies...
Sofiya Pathan, Asmita Ingale, Vidya Kapse, Dr. V. M. Dharashive, ...
Development and Validation of RP-HPLC Method for the Simultaneous Estimation of ...
Dattatray Yadav, Dr. Deepak Kardile, Dr. Vishwas Bhagat, Tushar Shinde, Dr. Rajkumar Shete, ...
More related articles
Exploring Digital Health Literacy among the Elderly Population in North Karnatak...
Binu K M, H. Doddayya, Akshay J, Nuzhat Fatima, Pranotosh Mondal, Shifa Anjum, Toufeeq Rasheed, ...